Partial Surface Modification of Low Generation Polyamidoamine Dendrimers: Gaining Insight into their Potential for Improved Carboplatin Delivery

Abstract

Carboplatin (CAR) is a second generation platinum-based compound emerging as one of the most widely used anticancer drugs to treat a variety of tumors. In an attempt to address its dose-limiting toxicity and fast renal clearance, several delivery systems (DDSs) have been developed for CAR. However, unsuitable size range and low loading capacity may limit their potential applications. In this study, PAMAM G3.0 dendrimer was prepared and partially surface modified with methoxypolyethylene glycol (mPEG) for the delivery of CAR. The CAR/PAMAM G3.0@mPEG was successfully obtained with a desirable size range and high entrapment efficiency, improving the limitations of previous CAR-loaded DDSs. Cytocompatibility of PAMAM G3.0@mPEG was also examined, indicating that the system could be safely used. Notably, an in vitro release test and cell viability assays against HeLa, A549, and MCF7 cell lines indicated that CAR/PAMAM G3.0@mPEG could provide a sustained release of CAR while fully retaining its bioactivity to suppress the proliferation of cancer cells. These obtained results provide insights into the potential of PAMAM G3.0@mPEG dendrimer as an efficient delivery system for the delivery of a drug that has strong side effects and fast renal clearance like CAR, which could be a promising approach for cancer treatment.

Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature

“…Different functional groups can effectively accommodate therapeutic molecules and drugs on the dendrimer surface. [68][69][70] Nanosystems, particularly dendrimers, have been developed to prevent some of the limitations of various 7522 conventional drugs, including (i) low water solubility, (ii) a slight absorption, (iii) low targeted ability, (iv) strong affinity for plasma proteins, (v) speedy drug elimination, and (vi) low biodistribution affinity. 71 To be considered a promising excipient, the dendrimer must cross the organism's biological barriers.…”

Retrovirus Drugs-Loaded PEGylated PAMAM for Prolonging Drug Release and Enhancing Efficiency in HIV Treatment

“…However, higher-generation dendrimers and cationic dendrimers showed higher cytotoxicity [ 18 ]. Luckily, this drawback could be overcome by the modification of PAMAM’s surface with polyethylene glycol (PEG) [ 19 , 20 , 21 ]. This helps not only reduce the PAMAM’s cytotoxicity but also enhance the encapsulate capacity, permeability, and blood residence time of the modified particles [ 22 ].…”

Soy Lecithin-Derived Liposomal Delivery Systems: Surface Modification and Current Applications

“…The field of nanotechnology has provided the medical research fraternity with viable systems of delivering therapeutic substances, antioxidants, and nutrients to targeted areas of the body [1,2]. Consequently, a wide range of nanomaterials has been developed and their efficacy and safety as delivery systems tested [3,4,5,6,7,8]. Among different types of carriers, liposome has been discovered and subsequently developed and applied in the medical field [9,10,11].…”